Revvity | PKI - 营业费用



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.34B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


营业费用 更改 日
Agilent USD 1.44B 9M 2026-03
Align Technology USD 862.03M 39.18M 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Celltrion KRW 140.68B 584.31B 2025-12
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Illumina USD 852M 51M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 6.3M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 42.28M 4.59M 2026-03
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 1.85B 1.09B 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Waters USD 1.12B 457.15M 2026-03
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03